<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01179048</url>
  </required_header>
  <id_info>
    <org_study_id>EX2211-3748</org_study_id>
    <secondary_id>2009-012201-19</secondary_id>
    <secondary_id>U1111-1113-7090</secondary_id>
    <secondary_id>CTR20130003</secondary_id>
    <nct_id>NCT01179048</nct_id>
  </id_info>
  <brief_title>Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results</brief_title>
  <acronym>LEADERÂ®</acronym>
  <official_title>A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novo Nordisk A/S</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is conducted in Africa, Asia, Europe, and North and South America. The aim of this
      trial is to determine the long term effect of liraglutide on cardiovascular events in
      subjects with type 2 diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 31, 2010</start_date>
  <completion_date type="Actual">December 17, 2015</completion_date>
  <primary_completion_date type="Actual">December 17, 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time From Randomisation to First Occurrence of Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal Stroke (a Composite Cardiovascular Outcome)</measure>
    <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
    <description>Time from randomisation to first occurrence of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke (a composite cardiovascular outcome). The percentage of subjects experiencing a first event of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke (a composite cardiovascular outcome) is presented.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time From Rand. to First Occurrence of an Expanded Composite Cardiovascular Outcome Defined as Either Cardiovascular Death, Non-fatal Myocardial Infarction, Non-fatal Stroke, Revascularisation, Hospitalisation for Unstable Angina or for Heart Failure.</measure>
    <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
    <description>Time from randomisation to first occurrence of an expanded composite cardiovascular outcome defined as either cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularisation, hospitalisation for unstable angina or for heart failure. The percentage of subjects experiencing first occurrence of an expanded composite cardiovascular outcome defined as either cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularisation, hospitalisation for unstable angina or for heart failure is presented.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomisation to All Cause Death</measure>
    <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
    <description>Time from randomisation to all cause death. The percentage of subjects with a death by any cause (all-cause death) is presented.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomisation to Each Individual Component of the Expanded Composite Cardiovascular Outcome</measure>
    <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
    <description>Time from randomisation to each individual component of the expanded composite cardiovascular outcome. The percentage of subjects experiencing each of the individual component of the expanded composite cardiovascular outcome (defined as either cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularisation, hospitalisation for unstable angina or heart failure) is presented.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomisation to First Occurrence of a Composite Microvascular Outcome</measure>
    <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
    <description>Time from randomisation to first occurrence of a composite microvascular outcome, defined as any one of the following:
new onset of persistent macroalbuminuria
persistent doubling of serum creatinine
need for continuous renal replacement therapy
death due to renal disease
need for retinal photocoagulation or treatment with intravitreal agents
vitreous haemorrhage
diabetes-related blindness
The percentage of subjects experiencing a first occurrence of a composite microvascular outcome is presented.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomisation to Each Individual Component of the Composite Microvascular Outcome and to the Retinopathy and Nephropathy Composite Outcomes Separately.</measure>
    <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
    <description>Time from randomisation to each individual component of the composite microvascular outcome and to the retinopathy and nephropathy composite outcomes separately. The percentage of subjects experiencing each individual component of the composite microvascular outcome are presented.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9340</enrollment>
  <condition>Diabetes</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Liraglutide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>liraglutide</intervention_name>
    <description>Maximum dose of 1.8 mg liraglutide, injected subcutaneously (under the skin) once daily. Administered in addition to the subject's standard treatment</description>
    <arm_group_label>Liraglutide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Maximum dose of 1.8 mg placebo, injected subcutaneously (under the skin) once daily. Administered in addition to the subject's standard treatment</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes

          -  Age min. 50 years at screening and concomitant cardiovascular, cerebrovascular or
             peripheral vascular disease or chronic renal failure or chronic heart failure OR age
             min. 60 years at screening and other specified risk factors of cardiovascular disease

          -  HbA1c: 7.0% or above

          -  Anti-diabetic drug naive or treated with one or more oral anti-diabetic drugs (OADs)
             or treated with human NPH insulin or long-acting insulin analogue or premixed insulin,
             alone or in combination with OAD(s)

        Exclusion Criteria:

          -  Type 1 diabetes

          -  Use of a glucagon-like peptide-1 (GLP-1) receptor agonist (exenatide, liraglutide or
             other) or pramlintide or any dipeptidyl peptidase 4 (DPP-4) inhibitor within the 3
             months prior to screening (trial start)

          -  Use of insulin other than human NPH insulin or long-acting insulin analogue or
             premixed insulin within 3 months prior to screening. Short-term use of other insulin
             during this period in connection with intercurrent illness is allowed, at
             Investigator's discretion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Global Clinical Registry (GCR, 1452)</last_name>
    <role>Study Director</role>
    <affiliation>Novo Nordisk A/S</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Alabaster</city>
        <state>Alabama</state>
        <zip>35007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85283</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205-5446</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cerritos</city>
        <state>California</state>
        <zip>90703-2115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Escondido</city>
        <state>California</state>
        <zip>92025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93721-1443</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90017-4006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Los Banos</city>
        <state>California</state>
        <zip>93635</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mission Hills</city>
        <state>California</state>
        <zip>91345</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Montclair</city>
        <state>California</state>
        <zip>91763</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <zip>92780</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Watsonville</city>
        <state>California</state>
        <zip>95076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045-7402</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>DeLand</city>
        <state>Florida</state>
        <zip>32724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <zip>34744</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33711</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33624</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33409</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lawrenceville</city>
        <state>Georgia</state>
        <zip>30046</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Roswell</city>
        <state>Georgia</state>
        <zip>30076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60654</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Crystal Lake</city>
        <state>Illinois</state>
        <zip>60012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260-1992</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Michigan City</city>
        <state>Indiana</state>
        <zip>46360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50265</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006-2930</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Monroe</city>
        <state>Louisiana</state>
        <zip>71203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Natchitoches</city>
        <state>Louisiana</state>
        <zip>71457-5881</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218-2829</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bloomfield Hills</city>
        <state>Michigan</state>
        <zip>48302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dearborn</city>
        <state>Michigan</state>
        <zip>48124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Interlochen</city>
        <state>Michigan</state>
        <zip>49643</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48085-5524</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nashua</city>
        <state>New Hampshire</state>
        <zip>03063</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mine Hill</city>
        <state>New Jersey</state>
        <zip>07803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753-4859</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14221-7091</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Smithtown</city>
        <state>New York</state>
        <zip>11787</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Westfield</city>
        <state>New York</state>
        <zip>14787</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Burlington</city>
        <state>North Carolina</state>
        <zip>27215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27517</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Monroe</city>
        <state>North Carolina</state>
        <zip>28110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mooresville</city>
        <state>North Carolina</state>
        <zip>28117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Morehead City</city>
        <state>North Carolina</state>
        <zip>28557</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Whiteville</city>
        <state>North Carolina</state>
        <zip>28472</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cadiz</city>
        <state>Ohio</state>
        <zip>43907</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220-2213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Marion</city>
        <state>Ohio</state>
        <zip>43302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Middleburg Heights</city>
        <state>Ohio</state>
        <zip>44310</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Altoona</city>
        <state>Pennsylvania</state>
        <zip>16602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Beaver</city>
        <state>Pennsylvania</state>
        <zip>15009-1957</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hatfield</city>
        <state>Pennsylvania</state>
        <zip>19440</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15243</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Uniontown</city>
        <state>Pennsylvania</state>
        <zip>15401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29651</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Murrells Inlet</city>
        <state>South Carolina</state>
        <zip>29576</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Myrtle Beach</city>
        <state>South Carolina</state>
        <zip>29572</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bartlett</city>
        <state>Tennessee</state>
        <zip>38133</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38163</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Arlington</city>
        <state>Texas</state>
        <zip>76014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <zip>78404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77070</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Longview</city>
        <state>Texas</state>
        <zip>75605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79423</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Odessa</city>
        <state>Texas</state>
        <zip>79761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78228-3419</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Schertz</city>
        <state>Texas</state>
        <zip>78154</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tomball</city>
        <state>Texas</state>
        <zip>77375</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>South Burlington</city>
        <state>Vermont</state>
        <zip>05403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53717</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Blacktown</city>
        <state>New South Wales</state>
        <zip>2148</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Douglas</city>
        <state>Queensland</state>
        <zip>4814</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Meadowbrook</city>
        <state>Queensland</state>
        <zip>4131</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Keswick</city>
        <state>South Australia</state>
        <zip>5035</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Oaklands Park</city>
        <state>South Australia</state>
        <zip>5046</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hobart</city>
        <state>Tasmania</state>
        <zip>7000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Box Hill</city>
        <state>Victoria</state>
        <zip>3128</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fitzroy</city>
        <state>Victoria</state>
        <zip>3065</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fremantle</city>
        <state>Western Australia</state>
        <zip>6160</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Wien</city>
        <zip>1030</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Wien</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Wien</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Edegem</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>LiÃ¨ge</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fortaleza</city>
        <state>Ceara</state>
        <zip>60115-282</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fortaleza</city>
        <state>Ceara</state>
        <zip>60160-230</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fortaleza</city>
        <state>Ceara</state>
        <zip>60170-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Aparecida de Goiania</city>
        <state>Goias</state>
        <zip>74935-530</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Curitiba</city>
        <state>Parana</state>
        <zip>80010-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Curitiba</city>
        <state>Parana</state>
        <zip>80030-110</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>BelÃ©m</city>
        <state>Para</state>
        <zip>66073-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Caxias Do Sul</city>
        <state>Rio Grande Do Sul</state>
        <zip>95070-560</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande Do Sul</state>
        <zip>90035-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Campinas</city>
        <state>Sao Paulo</state>
        <zip>13059-740</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Campinas</city>
        <state>Sao Paulo</state>
        <zip>13073-350</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mogi das Cruzes</city>
        <state>Sao Paulo</state>
        <zip>08780-090</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>SÃ£o Paulo</city>
        <state>Sao Paulo</state>
        <zip>01223-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>SÃ£o Paulo</city>
        <state>Sao Paulo</state>
        <zip>01228-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>SÃ£o Paulo</city>
        <state>Sao Paulo</state>
        <zip>01244-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>SÃ£o Paulo</city>
        <state>Sao Paulo</state>
        <zip>04020-041</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>SÃ£o Paulo</city>
        <state>Sao Paulo</state>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>AracajÃº</city>
        <zip>49020-270</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Belo Horizonte</city>
        <zip>30150-221</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Campinas</city>
        <zip>13084-971</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Curitiba</city>
        <zip>80420-011</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Curitiba</city>
        <zip>80810-040</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fortaleza</city>
        <zip>60430-350</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>GoiÃ¢nia</city>
        <zip>74110-120</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Joinville</city>
        <zip>05001-100</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>MarÃ­lia</city>
        <zip>17519-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Porto Alegre</city>
        <zip>90035-170</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Recife</city>
        <zip>52020-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>20211-340</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>20551-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Santos</city>
        <zip>11045-904</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01323-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04011-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04012-909</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>SÃ£o Paulo</city>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5J 3N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 3P4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>St.John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1B 3V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 2Y9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <zip>N1R 7L6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cornwall</city>
        <state>Ontario</state>
        <zip>K6H 4M4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6G 2M1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5M 2V8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Scarborough</city>
        <state>Ontario</state>
        <zip>M1E 5E9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Smiths Falls</city>
        <state>Ontario</state>
        <zip>K7A 4W8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Thunder Bay</city>
        <state>Ontario</state>
        <zip>P7A 4V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C 2T2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 3L9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1R7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Xiamen</city>
        <state>Fujian</state>
        <zip>361003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Zhenjiang</city>
        <state>Jiangsu</state>
        <zip>212001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Qingdao</city>
        <state>Shandong</state>
        <zip>266003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Plzen</city>
        <zip>304 60</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Praha</city>
        <zip>128 08</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Aalborg</city>
        <zip>9100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Esbjerg</city>
        <zip>6700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Gentofte</city>
        <zip>2820</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ãrhus C</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kuopio</city>
        <zip>70210</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lahti</city>
        <zip>15110</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Oulu</city>
        <zip>90220</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tampere</city>
        <zip>33520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Vantaa</city>
        <zip>FIN-01600</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Corbeil Essonnes</city>
        <zip>91106</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Jarny</city>
        <zip>54800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nimes</city>
        <zip>30006</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Paris</city>
        <zip>75877</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>AngermÃ¼nde/OT Wolletz</city>
        <zip>16278</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Aschaffenburg</city>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>12163</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>13055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dillingen</city>
        <zip>89407</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dresden</city>
        <zip>01219</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Elsterwerda</city>
        <zip>04910</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Essen</city>
        <zip>45219</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Falkensee</city>
        <zip>14612</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Gifhorn</city>
        <zip>38518</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hamburg</city>
        <zip>22587</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Karlsbad</city>
        <zip>76307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Leipzig</city>
        <zip>04275</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67059</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mannheim</city>
        <zip>68163</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>MÃ¼nchen</city>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Oldenburg</city>
        <zip>23758</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Saint Ingbert</city>
        <zip>66386</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Schkeuditz</city>
        <zip>04435</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Schweinfurt</city>
        <zip>97421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Villingen-Schwenningen</city>
        <zip>78048</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Wangen</city>
        <zip>88239</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Athens</city>
        <zip>GR-10552</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Athens</city>
        <zip>GR-11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Crete</city>
        <zip>71001</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Thessaloniki</city>
        <zip>GR-57001</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hyderabad</city>
        <state>Andhra Pradesh</state>
        <zip>500034</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hyderbad</city>
        <state>Andhra Pradesh</state>
        <zip>500 012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Guwahati</city>
        <state>Assam</state>
        <zip>781007</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Karnal</city>
        <state>Haryana</state>
        <zip>132001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560 003</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560043</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560052</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Manipal</city>
        <state>Karnataka</state>
        <zip>576104</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kochi</city>
        <state>Kerala</state>
        <zip>682041</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Indore</city>
        <state>Madhya Pradesh</state>
        <zip>452010</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chandigarh</city>
        <state>Punjab</state>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>600029</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>600086</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Madurai</city>
        <state>Tamil Nadu</state>
        <zip>625 020</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Vellore</city>
        <state>Tamil Nadu</state>
        <zip>632004</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700054</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Thriruvananthapuram</city>
        <zip>695 032</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dublin 9</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dublin</city>
        <zip>DUBLIN 4</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Haifa</city>
        <zip>35152</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Petah-Tikva</city>
        <zip>49372</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chieti Scalo</city>
        <zip>66100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Firenze</city>
        <zip>50141</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Latina</city>
        <zip>04100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lucca</city>
        <zip>55100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Palermo</city>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Roma</city>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Roma</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Goyang</city>
        <zip>410-719</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Seongnam-si</city>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>02447</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>137-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>139-827</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tijuana</city>
        <state>Baja California Norte</state>
        <zip>22010</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44600</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44650</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Durango</city>
        <zip>34000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Durango</city>
        <zip>34080</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Monterrey</city>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Luis Potosi</city>
        <zip>78200</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Amsterdam</city>
        <zip>1066 EC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Eindhoven</city>
        <zip>5631 BM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Etten-Leur</city>
        <zip>4872 LP</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Goes</city>
        <zip>4461 LT</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Groningen</city>
        <zip>9728 NT</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hoogeveen</city>
        <zip>7909 AA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nijmegen</city>
        <zip>6525 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Utrecht</city>
        <zip>3584 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Oslo</city>
        <zip>0407</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Oslo</city>
        <zip>0586</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Stavanger</city>
        <zip>4011</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Trondheim</city>
        <zip>7030</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>TÃ¸nsberg</city>
        <zip>3117</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bialystok</city>
        <zip>15-435</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-822</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Katowice</city>
        <zip>40-084</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Krakow</city>
        <zip>31-261</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Krakow</city>
        <zip>31-271</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Krakow</city>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>93-338</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Poznan</city>
        <zip>60-569</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pulawy</city>
        <zip>24-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ruda Slaska</city>
        <zip>41-709</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <zip>01-192</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <zip>02-507</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-381</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bayamon</city>
        <zip>00961</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Caguas</city>
        <zip>00725</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Craiova</city>
        <state>Dolj</state>
        <zip>200642</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Targu Mures</city>
        <state>Mures</state>
        <zip>540098</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bacau</city>
        <zip>600114</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <zip>020475</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Constanta</city>
        <zip>900591</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Deva</city>
        <zip>330084</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Iasi</city>
        <zip>700547</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Satu Mare</city>
        <zip>440055</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sibiu</city>
        <zip>550245</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Timisoara</city>
        <zip>300736</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Arkhangelsk</city>
        <zip>163001</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Arkhangelsk</city>
        <zip>163045</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Barnaul</city>
        <zip>656045</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kazan</city>
        <zip>420043</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>117036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>119435</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>125367</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>127486</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nizhniy Novgorod</city>
        <zip>603126</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Penza</city>
        <zip>440026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Saratov</city>
        <zip>410053</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Smolensk</city>
        <zip>214019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tumen</city>
        <zip>625023</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150062</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bloemfontein</city>
        <state>Free State</state>
        <zip>9301</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Johannesburg</city>
        <state>Gauteng</state>
        <zip>1829</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Johannesburg</city>
        <state>Gauteng</state>
        <zip>2013</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lenasia</city>
        <state>Gauteng</state>
        <zip>1827</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Midrand</city>
        <state>Gauteng</state>
        <zip>1685</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <zip>0001</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <zip>0083</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <zip>0181</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Durban</city>
        <state>KwaZulu-Natal</state>
        <zip>4091</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Durban</city>
        <state>KwaZulu-Natal</state>
        <zip>4126</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Durban</city>
        <state>KwaZulu-Natal</state>
        <zip>4320</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tongaat</city>
        <state>KwaZulu-Natal</state>
        <zip>4400</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Somerset West</city>
        <state>Western Cape</state>
        <zip>7130</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Alberton</city>
        <zip>1449</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <zip>7530</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>AlmerÃ­a</city>
        <zip>04001</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>La CoruÃ±a</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mora De Ebre</city>
        <zip>43740</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mostoles - Madrid -</city>
        <zip>28935</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Palma de Mallorca</city>
        <zip>07198</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pozuelo de Alarcon</city>
        <zip>28223</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sevilla</city>
        <zip>41003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sevilla</city>
        <zip>41014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Valladolid</city>
        <zip>47005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>GÃ¶teborg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>MalmÃ¶</city>
        <zip>205 02</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Stockholm</city>
        <zip>111 57</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Stockholm</city>
        <zip>113 24</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Stockholm</city>
        <zip>141 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ãrebro</city>
        <zip>701 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Changhua</city>
        <zip>500</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kaoshiung</city>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tainan city</city>
        <zip>710</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Taoyuan</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ankara</city>
        <zip>06500</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Antalya</city>
        <zip>07058</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bursa</city>
        <zip>16059</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Gaziantep</city>
        <zip>27070</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34096</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34098</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34360</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34371</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34390</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34722</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34890</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Izmir</city>
        <zip>35100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Izmir</city>
        <zip>35340</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kayseri</city>
        <zip>38039</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dubai</city>
        <zip>4545</zip>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dubai</city>
        <zip>7272</zip>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Aberdeen</city>
        <zip>AB25 1LD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bristol</city>
        <zip>BS10 5NB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Coventry</city>
        <zip>CV2 2DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Devon</city>
        <zip>EX2 5DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dundee</city>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Glasgow</city>
        <zip>G31 2ER</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Guildford</city>
        <zip>GU2 7XX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hull</city>
        <zip>HU3 2RW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Livington</city>
        <zip>EH54 6PP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>London</city>
        <zip>W2 1NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Manchester</city>
        <zip>M6 8HD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Norwich</city>
        <zip>NR4 7TJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nuneaton</city>
        <zip>CV10 7DJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Plymouth</city>
        <zip>PL6 8BQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>St Helens</city>
        <zip>WA9 3DA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Swansea</city>
        <zip>SA6 6NL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Torquay</city>
        <zip>TQ2 7AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>West Midlands</city>
        <zip>B71 4HJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>China</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>India</country>
    <country>Ireland</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Taiwan</country>
    <country>Turkey</country>
    <country>United Arab Emirates</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <link>
    <url>http://novonordisk-trials.com</url>
    <description>Clinical Trials at Novo Nordisk</description>
  </link>
  <results_reference>
    <citation>Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.</citation>
    <PMID>27295427</PMID>
  </results_reference>
  <results_reference>
    <citation>Petrie JR, Marso SP, Bain SC, Franek E, Jacob S, Masmiquel L, Leiter LA, Haluzik M, Satman I, Omar M, Shestakova M, Van Gaal L, Mann JF, Baeres FM, Zinman B, Poulter NR; LEADER investigators. LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial. J Hypertens. 2016 Jun;34(6):1140-50. doi: 10.1097/HJH.0000000000000890.</citation>
    <PMID>26855018</PMID>
  </results_reference>
  <results_reference>
    <citation>Masmiquel L, Leiter LA, Vidal J, Bain S, Petrie J, Franek E, Raz I, Comlekci A, Jacob S, van Gaal L, Baeres FM, Marso SP, Eriksson M; LEADER investigators. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial. Cardiovasc Diabetol. 2016 Feb 10;15:29. doi: 10.1186/s12933-016-0341-5.</citation>
    <PMID>26864124</PMID>
  </results_reference>
  <results_reference>
    <citation>Satman I, R Rea R, Eriksson M, Mosenzon O, Pratley R, M Baeres F, D Ãrsted D, F Mann J; LEADER Trial Investigators. LEADER-6: Baseline renal function and associated factors in a high cardiovascular risk type 2 diabetes population. J Diabetes Complications. 2016 Nov - Dec;30(8):1631-1639. doi: 10.1016/j.jdiacomp.2016.06.001. Epub 2016 Jun 3.</citation>
    <PMID>27320184</PMID>
  </results_reference>
  <results_reference>
    <citation>Rutten GE, Tack CJ, Pieber TR, Comlekci A, Ãrsted DD, Baeres FM, Marso SP, Buse JB; LEADER Investigators. LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ. Diabetol Metab Syndr. 2016 Jun 2;8:37. doi: 10.1186/s13098-016-0153-5. eCollection 2016.</citation>
    <PMID>27274772</PMID>
  </results_reference>
  <results_reference>
    <citation>Marso SP, Poulter NR, Nissen SE, Nauck MA, Zinman B, Daniels GH, Pocock S, Steinberg WM, Bergenstal RM, Mann JF, Ravn LS, Frandsen KB, Moses AC, Buse JB. Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. Am Heart J. 2013 Nov;166(5):823-30.e5. doi: 10.1016/j.ahj.2013.07.012. Epub 2013 Oct 2.</citation>
    <PMID>24176437</PMID>
  </results_reference>
  <results_reference>
    <citation>Steinberg WM, Nauck MA, Zinman B, Daniels GH, Bergenstal RM, Mann JF, Steen Ravn L, Moses AC, Stockner M, Baeres FM, Marso SP, Buse JB; LEADER Trial investigators. LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial. Pancreas. 2014 Nov;43(8):1223-31. doi: 10.1097/MPA.0000000000000229.</citation>
    <PMID>25275271</PMID>
  </results_reference>
  <results_reference>
    <citation>Daniels GH, HegedÃ¼s L, Marso SP, Nauck MA, Zinman B, Bergenstal RM, Mann JF, Derving KarsbÃ¸l J, Moses AC, Buse JB, Tuttle RM; LEADER Trial Investigators. LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations. Diabetes Obes Metab. 2015 May;17(5):477-86. doi: 10.1111/dom.12444. Epub 2015 Feb 23.</citation>
    <PMID>25656058</PMID>
  </results_reference>
  <results_reference>
    <citation>Steinberg WM, Buse JB, Ghorbani MLM, Ãrsted DD, Nauck MA; LEADER Steering Committee; LEADER Trial Investigators. Amylase, Lipase, and Acute Pancreatitis in People With Type 2 Diabetes Treated With Liraglutide: Results From the LEADER Randomized Trial. Diabetes Care. 2017 Jul;40(7):966-972. doi: 10.2337/dc16-2747. Epub 2017 May 5.</citation>
    <PMID>28476871</PMID>
  </results_reference>
  <results_reference>
    <citation>Mann JFE, Ãrsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, TornÃ¸e K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Liraglutide and Renal Outcomes in Type 2 Diabetes. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.</citation>
    <PMID>28854085</PMID>
  </results_reference>
  <results_reference>
    <citation>HegedÃ¼s L, Sherman SI, Tuttle RM, von Scholten BJ, Rasmussen S, KarsbÃ¸l JD, Daniels GH; LEADER Publication Committee on behalf of the LEADER Trial Investigators. No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial. Diabetes Care. 2018 Mar;41(3):620-622. doi: 10.2337/dc17-1956. Epub 2017 Dec 26.</citation>
    <PMID>29279300</PMID>
  </results_reference>
  <results_reference>
    <citation>Marso SP, Nauck MA, Monk Fries T, Rasmussen S, Treppendahl MB, Buse JB; LEADER Publication Committee on behalf of the LEADER Trial Investigators. Myocardial Infarction Subtypes in Patients With Type 2 Diabetes Mellitus and the Effect of Liraglutide Therapy (from the LEADER Trial). Am J Cardiol. 2018 Mar 15. pii: S0002-9149(18)30266-2. doi: 10.1016/j.amjcard.2018.02.030. [Epub ahead of print]</citation>
    <PMID>29627109</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2010</study_first_submitted>
  <study_first_submitted_qc>August 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2010</study_first_posted>
  <results_first_submitted>December 16, 2016</results_first_submitted>
  <results_first_submitted_qc>January 10, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 1, 2017</results_first_posted>
  <last_update_submitted>April 20, 2018</last_update_submitted>
  <last_update_submitted_qc>April 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liraglutide</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>410 sites in 32 countries across the 4 regions recruited subjects. Number of sites that recruited subjects is given in parenthesis. Europe (143), North America (135) (US, Canada) , Asia (33) (China, Taiwan, Korea, India) and Rest of the world (99) (Brazil, Mexico, Australia, South Africa, Turkey, Russian Federation, United Arab Emirates).</recruitment_details>
      <pre_assignment_details>All subjects received placebo (0.6 mg/day) during the open labeled run-in period of 2-3 weeks and were instructed on how to administer the trial product. During this period the subjects demonstrated that they could adhere to the injection regimen in the trial.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Liraglutide</title>
          <description>Subjects received liraglutide once daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Liraglutide was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Subjects received placebo (matched to liraglutide) daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Placebo was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4668"/>
                <participants group_id="P2" count="4672"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4529"/>
                <participants group_id="P2" count="4513"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="139"/>
                <participants group_id="P2" count="159"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawn - does not allow contact</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Alive</title>
              <participants_list>
                <participants group_id="P1" count="127"/>
                <participants group_id="P2" count="142"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All the randomised subjects.</population>
      <group_list>
        <group group_id="B1">
          <title>Liraglutide</title>
          <description>Subjects received liraglutide once daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Liraglutide was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Subjects received placebo (matched to liraglutide) daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Placebo was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4668"/>
            <count group_id="B2" value="4672"/>
            <count group_id="B3" value="9340"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.2" spread="7.2"/>
                    <measurement group_id="B2" value="64.4" spread="7.2"/>
                    <measurement group_id="B3" value="64.3" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Between 18 and 64 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2512"/>
                    <measurement group_id="B2" value="2499"/>
                    <measurement group_id="B3" value="5011"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 65 to 84 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2139"/>
                    <measurement group_id="B2" value="2148"/>
                    <measurement group_id="B3" value="4287"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>85 years and over</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1657"/>
                    <measurement group_id="B2" value="1680"/>
                    <measurement group_id="B3" value="3337"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3011"/>
                    <measurement group_id="B2" value="2992"/>
                    <measurement group_id="B3" value="6003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time From Randomisation to First Occurrence of Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal Stroke (a Composite Cardiovascular Outcome)</title>
        <description>Time from randomisation to first occurrence of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke (a composite cardiovascular outcome). The percentage of subjects experiencing a first event of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke (a composite cardiovascular outcome) is presented.</description>
        <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
        <population>All randomised subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Liraglutide</title>
            <description>Subjects received liraglutide once daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Liraglutide was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects received placebo (matched to liraglutide) daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Placebo was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomisation to First Occurrence of Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal Stroke (a Composite Cardiovascular Outcome)</title>
          <description>Time from randomisation to first occurrence of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke (a composite cardiovascular outcome). The percentage of subjects experiencing a first event of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke (a composite cardiovascular outcome) is presented.</description>
          <population>All randomised subjects.</population>
          <units>percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4668"/>
                <count group_id="O2" value="4672"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.0"/>
                    <measurement group_id="O2" value="14.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The primary endpoint was evaluated using the Cox regression model to estimate the hazard ratio (HR) (liraglutide/placebo) and the 2-sided 95% confidence interval (CI) including treatment group as factor. Non-inferiority of liraglutide versus placebo was considered confirmed, if the upper limit of the two-sided 95% CI for the hazard ratio was below 1.3 or if the p-value for the one-sided test of H0: HR &gt;=1.3 against Ha: HR &lt;1.3 was less than 2.5% (or equivalent to 5% in two-sided test).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority of liraglutide versus placebo was considered confirmed, if the upper limit of the two-sided 95% CI for the hazard ratio was below 1.3 or if the p-value for the one-sided test of H0: HR &gt;=1.3 against Ha: HR &lt;1.3 was less than 2.5% (or equivalent to 5% in two-sided test). If non-inferiority was established for the primary outcome, a test for superiority was to be performed.</non_inferiority_desc>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>p-value is reported for one-sided (Î±-level 0.025) test for non-inferiority (hazard ratio &gt;=1.3).</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.868</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.778</ci_lower_limit>
            <ci_upper_limit>0.968</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>If non-inferiority was established for the primary outcome, a test for superiority was performed. Superiority of liraglutide versus placebo was considered confirmed, if the upper limit of the two-sided 95% CI for the hazard ratio was below 1.0 or equivalent if the p-value for the one-sided test of H0: HR &gt;=1.0 against Ha: HR &lt;1.0 was less than 2.5% (or equivalent to 5% in two-sided test).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <p_value_desc>p-value is reported for one-sided (Î±-level 0.025) test for superiority (hazard ratio&gt;=1.0).</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.868</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.778</ci_lower_limit>
            <ci_upper_limit>0.968</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Rand. to First Occurrence of an Expanded Composite Cardiovascular Outcome Defined as Either Cardiovascular Death, Non-fatal Myocardial Infarction, Non-fatal Stroke, Revascularisation, Hospitalisation for Unstable Angina or for Heart Failure.</title>
        <description>Time from randomisation to first occurrence of an expanded composite cardiovascular outcome defined as either cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularisation, hospitalisation for unstable angina or for heart failure. The percentage of subjects experiencing first occurrence of an expanded composite cardiovascular outcome defined as either cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularisation, hospitalisation for unstable angina or for heart failure is presented.</description>
        <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
        <population>All randomised subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Liraglutide</title>
            <description>Subjects received liraglutide once daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Liraglutide was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects received placebo (matched to liraglutide) daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Placebo was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Rand. to First Occurrence of an Expanded Composite Cardiovascular Outcome Defined as Either Cardiovascular Death, Non-fatal Myocardial Infarction, Non-fatal Stroke, Revascularisation, Hospitalisation for Unstable Angina or for Heart Failure.</title>
          <description>Time from randomisation to first occurrence of an expanded composite cardiovascular outcome defined as either cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularisation, hospitalisation for unstable angina or for heart failure. The percentage of subjects experiencing first occurrence of an expanded composite cardiovascular outcome defined as either cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularisation, hospitalisation for unstable angina or for heart failure is presented.</description>
          <population>All randomised subjects.</population>
          <units>percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4668"/>
                <count group_id="O2" value="4672"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.3"/>
                    <measurement group_id="O2" value="22.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.881</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.807</ci_lower_limit>
            <ci_upper_limit>0.962</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomisation to All Cause Death</title>
        <description>Time from randomisation to all cause death. The percentage of subjects with a death by any cause (all-cause death) is presented.</description>
        <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
        <population>All randomised subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Liraglutide</title>
            <description>Subjects received liraglutide once daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Liraglutide was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects received placebo (matched to liraglutide) daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Placebo was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomisation to All Cause Death</title>
          <description>Time from randomisation to all cause death. The percentage of subjects with a death by any cause (all-cause death) is presented.</description>
          <population>All randomised subjects</population>
          <units>percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4668"/>
                <count group_id="O2" value="4672"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2"/>
                    <measurement group_id="O2" value="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.847</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.739</ci_lower_limit>
            <ci_upper_limit>0.971</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomisation to Each Individual Component of the Expanded Composite Cardiovascular Outcome</title>
        <description>Time from randomisation to each individual component of the expanded composite cardiovascular outcome. The percentage of subjects experiencing each of the individual component of the expanded composite cardiovascular outcome (defined as either cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularisation, hospitalisation for unstable angina or heart failure) is presented.</description>
        <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
        <population>All the randomised subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Liraglutide</title>
            <description>Subjects received liraglutide once daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Liraglutide was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects received placebo (matched to liraglutide) daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Placebo was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomisation to Each Individual Component of the Expanded Composite Cardiovascular Outcome</title>
          <description>Time from randomisation to each individual component of the expanded composite cardiovascular outcome. The percentage of subjects experiencing each of the individual component of the expanded composite cardiovascular outcome (defined as either cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularisation, hospitalisation for unstable angina or heart failure) is presented.</description>
          <population>All the randomised subjects.</population>
          <units>percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4668"/>
                <count group_id="O2" value="4672"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cardiovascular death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7"/>
                    <measurement group_id="O2" value="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-fatal stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4"/>
                    <measurement group_id="O2" value="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-fatal myocardial infarction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0"/>
                    <measurement group_id="O2" value="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unstable angina pectoris (hospitalisation)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6"/>
                    <measurement group_id="O2" value="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Coronary revascularisation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7"/>
                    <measurement group_id="O2" value="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Heart failure (hospitalisation)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7"/>
                    <measurement group_id="O2" value="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing cardiovascular death was done by Cox regression model with treatment as fixed factor.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.783</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.656</ci_lower_limit>
            <ci_upper_limit>0.934</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing non-fatal stroke was done by Cox regression model with treatment as fixed factor</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.894</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.721</ci_lower_limit>
            <ci_upper_limit>1.107</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing non-fatal myocardial infarction was done by Cox regression model with treatment as fixed factor</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.878</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.747</ci_lower_limit>
            <ci_upper_limit>1.031</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing hospitalisation for unstable angina pectoris was done by Cox regression model with treatment as fixed factor</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.980</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.763</ci_lower_limit>
            <ci_upper_limit>1.258</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing coronary revascularisation was done by Cox regression model with treatment as fixed factor</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.912</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.797</ci_lower_limit>
            <ci_upper_limit>1.044</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing hospitalisation for heart failure was done by Cox regression model with treatment as fixed factor</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.872</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.727</ci_lower_limit>
            <ci_upper_limit>1.046</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomisation to First Occurrence of a Composite Microvascular Outcome</title>
        <description>Time from randomisation to first occurrence of a composite microvascular outcome, defined as any one of the following:
new onset of persistent macroalbuminuria
persistent doubling of serum creatinine
need for continuous renal replacement therapy
death due to renal disease
need for retinal photocoagulation or treatment with intravitreal agents
vitreous haemorrhage
diabetes-related blindness
The percentage of subjects experiencing a first occurrence of a composite microvascular outcome is presented.</description>
        <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
        <population>All randomised subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Liraglutide</title>
            <description>Subjects received liraglutide once daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Liraglutide was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects received placebo (matched to liraglutide) daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Placebo was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomisation to First Occurrence of a Composite Microvascular Outcome</title>
          <description>Time from randomisation to first occurrence of a composite microvascular outcome, defined as any one of the following:
new onset of persistent macroalbuminuria
persistent doubling of serum creatinine
need for continuous renal replacement therapy
death due to renal disease
need for retinal photocoagulation or treatment with intravitreal agents
vitreous haemorrhage
diabetes-related blindness
The percentage of subjects experiencing a first occurrence of a composite microvascular outcome is presented.</description>
          <population>All randomised subjects.</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4668"/>
                <count group_id="O2" value="4672"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.6"/>
                    <measurement group_id="O2" value="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing a first microvascular event was done by Cox regression model with treatment as fixed factor.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.841</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.730</ci_lower_limit>
            <ci_upper_limit>0.969</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomisation to Each Individual Component of the Composite Microvascular Outcome and to the Retinopathy and Nephropathy Composite Outcomes Separately.</title>
        <description>Time from randomisation to each individual component of the composite microvascular outcome and to the retinopathy and nephropathy composite outcomes separately. The percentage of subjects experiencing each individual component of the composite microvascular outcome are presented.</description>
        <time_frame>from randomisation (visit 3; month 0) to last contact (visit 16; up to month 60+30 days)</time_frame>
        <population>All randomised subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Liraglutide</title>
            <description>Subjects received liraglutide once daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Liraglutide was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects received placebo (matched to liraglutide) daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Placebo was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomisation to Each Individual Component of the Composite Microvascular Outcome and to the Retinopathy and Nephropathy Composite Outcomes Separately.</title>
          <description>Time from randomisation to each individual component of the composite microvascular outcome and to the retinopathy and nephropathy composite outcomes separately. The percentage of subjects experiencing each individual component of the composite microvascular outcome are presented.</description>
          <population>All randomised subjects</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4668"/>
                <count group_id="O2" value="4672"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nephropathy composite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7"/>
                    <measurement group_id="O2" value="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New onset of persistent macroalbuminuria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4"/>
                    <measurement group_id="O2" value="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Persistent doubling of serum creatinine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9"/>
                    <measurement group_id="O2" value="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Need for continuous renal-replacement therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Death due to renal disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2"/>
                    <measurement group_id="O2" value="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Retinopathy composite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3"/>
                    <measurement group_id="O2" value="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treatment with photocoagulation/intravitreal agent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1"/>
                    <measurement group_id="O2" value="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Development of diabetes-related blindness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vitreous haemorrhage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7"/>
                    <measurement group_id="O2" value="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing a composite nephropathy event was done by Cox regression model with treatment as fixed factor.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.782</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.666</ci_lower_limit>
            <ci_upper_limit>0.918</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing a new onset of persistant macroalbuminaria event was done by Cox regression model with treatment as fixed factor.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.738</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.602</ci_lower_limit>
            <ci_upper_limit>0.905</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing persistent doubling of serum creatinine was done by Cox regression model with treatment as fixed factor.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.890</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.667</ci_lower_limit>
            <ci_upper_limit>1.189</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing a need for continuous renal-replacement therapy was done by Cox regression model with treatment as fixed factor.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.869</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.607</ci_lower_limit>
            <ci_upper_limit>1.244</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing death due to renal disease was done by Cox regression model with treatment as fixed factor.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.593</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.521</ci_lower_limit>
            <ci_upper_limit>4.869</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing composite retinopathy was done by Cox regression model with treatment as fixed factor.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.149</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.869</ci_lower_limit>
            <ci_upper_limit>1.519</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing treatment with photocoagulation or intravitreal agents was done by Cox regression model with treatment as fixed factor.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.159</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.869</ci_lower_limit>
            <ci_upper_limit>1.546</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing development of diabetes-related blindness was done by Cox regression model with treatment as fixed factor.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.335</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.004</ci_lower_limit>
            <ci_upper_limit>30.847</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for percentage of subjects experiencing vitreous haemorrhage was done by Cox regression model with treatment as fixed factor.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.454</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.845</ci_lower_limit>
            <ci_upper_limit>2.502</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events from randomisation (visit 3; month 0) and until follow up (visit 16; up to month 60+30 days of post-treatment follow-up).</time_frame>
      <desc>Safety was assessed using the full analysis set which included all randomised subjects.
Serious adverse events were systematically collected. Non-serious adverse events included both systematically collected as well as non-systematically collected adverse events.</desc>
      <group_list>
        <group group_id="E1">
          <title>Liraglutide</title>
          <description>Subjects received liraglutide once daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Liraglutide was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Subjects received placebo (matched to liraglutide) daily by subcutaneous injection in the abdomen, thigh or upper arm, at any time of the day and irrespective of meals, for a treatment period of 42 to 60 months. It was recommended to keep the time of injection consistent from day to day. Placebo was initiated at a dose of 0.6 mg and up-titrated to 1.2 mg after 1 week and to 1.8 mg after one additional week up to 42-60 months.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2320" subjects_at_risk="4668"/>
                <counts group_id="E2" subjects_affected="2354" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="32" subjects_affected="31" subjects_at_risk="4668"/>
                <counts group_id="E2" events="22" subjects_affected="21" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Anaemia macrocytic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Anaemia megaloblastic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Anaemia vitamin B12 deficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemolytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypochromic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Immune thrombocytopenic purpura</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Normochromic normocytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Paratracheal lymphadenopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Polycythaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Splenic embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Splenic infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Splenomegaly</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="41" subjects_affected="37" subjects_at_risk="4668"/>
                <counts group_id="E2" events="59" subjects_affected="54" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Acute left ventricular failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="176" subjects_affected="155" subjects_at_risk="4668"/>
                <counts group_id="E2" events="211" subjects_affected="187" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Adams-Stokes syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="105" subjects_affected="93" subjects_at_risk="4668"/>
                <counts group_id="E2" events="106" subjects_affected="93" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="179" subjects_affected="144" subjects_at_risk="4668"/>
                <counts group_id="E2" events="180" subjects_affected="151" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic valve calcification</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic valve sclerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="113" subjects_affected="89" subjects_at_risk="4668"/>
                <counts group_id="E2" events="112" subjects_affected="97" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="20" subjects_affected="17" subjects_at_risk="4668"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atrioventricular dissociation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bundle branch block left</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bundle branch block right</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="4668"/>
                <counts group_id="E2" events="31" subjects_affected="31" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="138" subjects_affected="115" subjects_at_risk="4668"/>
                <counts group_id="E2" events="201" subjects_affected="137" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" events="11" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" events="28" subjects_affected="28" subjects_at_risk="4668"/>
                <counts group_id="E2" events="29" subjects_affected="25" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="180" subjects_affected="121" subjects_at_risk="4668"/>
                <counts group_id="E2" events="176" subjects_affected="129" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac valve disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac ventricular thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="4668"/>
                <counts group_id="E2" events="15" subjects_affected="13" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiorenal syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiovascular insufficiency</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chordae tendinae rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cor pulmonale</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cor pulmonale acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cor pulmonale chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="77" subjects_affected="73" subjects_at_risk="4668"/>
                <counts group_id="E2" events="89" subjects_affected="87" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary artery insufficiency</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="4668"/>
                <counts group_id="E2" events="36" subjects_affected="35" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary ostial stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dilatation atrial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypertensive cardiomyopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypertensive heart disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Left ventricular hypertrophy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Microvascular coronary artery disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mitral valve calcification</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mitral valve stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Myocardial fibrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="71" subjects_affected="68" subjects_at_risk="4668"/>
                <counts group_id="E2" events="89" subjects_affected="84" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="4668"/>
                <counts group_id="E2" events="35" subjects_affected="33" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Myocarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nodal rhythm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pericardial cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pericardial haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pericarditis uraemic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumopericardium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Postural orthostatic tachycardia syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rhythm idioventricular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Silent myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sinus arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Stress cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Supraventricular extrasystoles</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Systolic dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tricuspid valve incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ventricular dyssynchrony</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ventricular hypokinesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="29" subjects_affected="18" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="8" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wolff-Parkinson-White syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous malformation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atrial septal defect</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Buried penis syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coarctation of the aorta</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Congenital cystic kidney disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dermoid cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hamartoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypertrophic cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intracranial lipoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreas divisum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Phimosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tracheo-oesophageal fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Aural polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Deafness bilateral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Deafness unilateral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Eustachian tube dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sudden hearing loss</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vestibular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Autoimmune thyroiditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cushing's syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypercorticoidism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism primary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypoaldosteronism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thyroid C-cell hyperplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thyroiditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thyroiditis subacute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Toxic nodular goitre</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Amaurosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Angle closure glaucoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aphakia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Autoimmune uveitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blepharitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blindness unilateral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="29" subjects_affected="24" subjects_at_risk="4668"/>
                <counts group_id="E2" events="35" subjects_affected="32" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Corneal erosion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic blindness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic retinal oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Iridocyclitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Iritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Macular fibrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Macular oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Macular rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Open angle glaucoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Optic ischaemic neuropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Optic nerve infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Papilloedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinal aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinal artery embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinal degeneration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinal infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinal vascular occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinal vein occlusion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinal vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinopathy haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retinopathy proliferative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ulcerative keratitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vitreous adhesions</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abdominal incarcerated hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abdominal mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="4668"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abdominal strangulated hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Acid peptic disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Acquired oesophageal web</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Anal fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Anal skin tags</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Barrett's oesophagus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiospasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Change of bowel habit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colonic pseudo-obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diverticulitis intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Duodenal perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Duodenal polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Enterocutaneous fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Enterovesical fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Epigastric discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Erosive oesophagitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Faecal incontinence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Faecalith</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastric antral vascular ectasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastric ulcer perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="4668"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="17" subjects_affected="14" subjects_at_risk="4668"/>
                <counts group_id="E2" events="27" subjects_affected="21" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastrointestinal hypomotility</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastrointestinal polyp haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Incarcerated hiatus hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Incarcerated inguinal hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Incarcerated umbilical hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Inflammatory bowel disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="15" subjects_affected="12" subjects_at_risk="4668"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intestinal polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Large intestinal ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="4668"/>
                <counts group_id="E2" events="18" subjects_affected="13" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mechanical ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mesenteric artery embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Obstruction gastric</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oedematous pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oesophageal achalasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oesophageal varices haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oesophagitis ulcerative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatic cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatic disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatic mass</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatic pseudocyst</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="20" subjects_affected="18" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="4668"/>
                <counts group_id="E2" events="22" subjects_affected="19" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatitis relapsing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peritoneal adhesions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peritoneal haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Proctitis ulcerative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Reactive gastropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rectal polyp</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rectal prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Reflux gastritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Retroperitoneal mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Salivary gland mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Short-bowel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="12" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="23" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Swollen tongue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tooth socket haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" events="8" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="20" subjects_affected="17" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adhesion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Catheter site haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="56" subjects_affected="53" subjects_at_risk="4668"/>
                <counts group_id="E2" events="52" subjects_affected="49" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="55" subjects_affected="55" subjects_at_risk="4668"/>
                <counts group_id="E2" events="47" subjects_affected="47" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Decreased activity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Device battery issue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Device leakage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Device occlusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Drowning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Drug interaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Granuloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ill-defined disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Incarcerated hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Local swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metaplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mucosal inflammation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="52" subjects_affected="45" subjects_at_risk="4668"/>
                <counts group_id="E2" events="73" subjects_affected="63" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Stent-graft endoleak</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thrombosis in device</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Autoimmune hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bile duct stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Biliary cirrhosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Biliary fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholangitis acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="35" subjects_affected="35" subjects_at_risk="4668"/>
                <counts group_id="E2" events="19" subjects_affected="18" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="45" subjects_affected="44" subjects_at_risk="4668"/>
                <counts group_id="E2" events="30" subjects_affected="30" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic hepatic failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cirrhosis alcoholic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cryptogenic cirrhosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Drug-induced liver injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gallbladder disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gallbladder perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gallbladder polyp</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatic cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatic lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatomegaly</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatorenal syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ischaemic hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Portal hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Portal vein thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Amyloidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Contrast media allergy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sarcoidosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abdominal wall abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abscess of salivary gland</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Acute hepatitis B</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arteriosclerotic gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atypical pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bacterial food poisoning</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Biliary sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Biliary tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Breast abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="4668"/>
                <counts group_id="E2" events="25" subjects_affected="24" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="21" subjects_affected="19" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Campylobacter gastroenteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carbuncle</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac valve abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="50" subjects_affected="37" subjects_at_risk="4668"/>
                <counts group_id="E2" events="61" subjects_affected="54" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cellulitis gangrenous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cellulitis of male external genital organ</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cervicitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholera</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Citrobacter sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Clostridium colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dacryocystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Device related sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dysentery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Endocarditis enterococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Endocarditis staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Enterobacter pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Enterococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Epididymitis ureaplasmal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="16" subjects_affected="14" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Escherichia bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Escherichia pyelonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Extradural abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gallbladder abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gallbladder empyema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gas gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastritis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="34" subjects_affected="33" subjects_at_risk="4668"/>
                <counts group_id="E2" events="31" subjects_affected="31" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastroenteritis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastroenteritis norovirus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastroenteritis salmonella</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastrointestinal viral infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gingivitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Helicobacter gastritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Herpes virus infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Human ehrlichiosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ileal gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Infected bites</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Infected dermal cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Infectious colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Infectious pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of bronchiectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disease</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Klebsiella bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Klebsiella sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Legionella infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Liver abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="4668"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="4668"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mastitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Meningitis pneumococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metapneumovirus infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neutropenic sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oesophageal candidiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="27" subjects_affected="21" subjects_at_risk="4668"/>
                <counts group_id="E2" events="30" subjects_affected="23" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Osteomyelitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Osteomyelitis chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Otitis media chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreas infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Parainfluenzae virus infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Penile infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Perichondritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peritonitis bacterial</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peritonsillar abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pilonidal cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Plasmodium falciparum infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumococcal sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="154" subjects_affected="133" subjects_at_risk="4668"/>
                <counts group_id="E2" events="157" subjects_affected="141" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumonia influenzal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumonia legionella</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumonia pneumococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumonia pseudomonal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumonia viral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post procedural cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post procedural sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Postoperative abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Prostatic abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pseudomembranous colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Psoas abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pulmonary mycosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="12" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="9" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pyuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rectal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Salmonella sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Salmonellosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Scrotal abscess</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="50" subjects_affected="48" subjects_at_risk="4668"/>
                <counts group_id="E2" events="36" subjects_affected="34" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sepsis syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Soft tissue infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Staphylococcal skin infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Streptococcal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Testicular abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tracheitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tuberculosis of genitourinary system</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="51" subjects_affected="47" subjects_at_risk="4668"/>
                <counts group_id="E2" events="79" subjects_affected="71" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="19" subjects_affected="17" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vaginal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Viral myocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Viral pharyngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Viral sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wound infection staphylococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wound sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Zygomycosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abdominal wound dehiscence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Acetabulum fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Afferent loop syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Anastomotic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arterial restenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula site complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Asbestosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Brain herniation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Burns second degree</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carbon monoxide poisoning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac valve replacement complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac valve rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carotid artery restenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cataract operation complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cataract traumatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Complications of transplanted kidney</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary artery reocclusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary artery restenosis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary vascular graft occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Delayed recovery from anaesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dialysis related complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Electric shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="94" subjects_affected="84" subjects_at_risk="4668"/>
                <counts group_id="E2" events="83" subjects_affected="81" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Fat embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Fracture displacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Frostbite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gun shot wound</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Heat exhaustion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Human bite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Incorrect dose administered</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Inflammation of wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intentional overdose</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Jaw fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Limb traumatic amputation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Muscle rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral arterial reocclusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral artery restenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post laminectomy syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post procedural fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post procedural hypothyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post procedural myocardial infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post procedural pulmonary embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post procedural stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post-traumatic pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Postoperative fever</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Postoperative hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Postoperative respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Postoperative thoracic procedure complication</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Postoperative thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Postoperative wound complication</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Procedural haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Procedural intestinal perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Radiation pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Respiratory fume inhalation disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="23" subjects_affected="20" subjects_at_risk="4668"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Scapula fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Shunt occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Skeletal injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Soft tissue injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Spinal cord injury thoracic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Stab wound</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sternal fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Subcutaneous haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tracheostomy malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Traumatic arthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Traumatic arthrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Traumatic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urinary retention postoperative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vascular graft occlusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vascular graft thrombosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wound decomposition</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wound haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wound necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wrong drug administered</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Ammonia increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Amylase increased</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Angiogram peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arteriogram coronary</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood alcohol increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood calcitonin increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood glucose fluctuation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="8" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood iron decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood magnesium decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood potassium decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood pressure decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood pressure systolic increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood urea increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac murmur</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac stress test abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiovascular evaluation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Catheterisation cardiac</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colonoscopy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colonoscopy normal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Culture urine positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>ECG signs of myocardial ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ejection fraction decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Glomerular filtration rate decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Glycosylated haemoglobin increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Imaging procedure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Inflammatory marker increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>International normalised ratio decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Left ventricular end-diastolic pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lipase increased</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Myocardial necrosis marker increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatic enzymes increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Red blood cell sedimentation rate increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal function test</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Serum ferritin decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Transplant evaluation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urine albumin/creatinine ratio increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cell death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="30" subjects_affected="30" subjects_at_risk="4668"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="28" subjects_affected="25" subjects_at_risk="4668"/>
                <counts group_id="E2" events="47" subjects_affected="43" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dyslipidaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Fluid retention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="35" subjects_affected="34" subjects_at_risk="4668"/>
                <counts group_id="E2" events="52" subjects_affected="49" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hyperlipidaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hyperosmolar hyperglycaemic state</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypervolaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="60" subjects_affected="44" subjects_at_risk="4668"/>
                <counts group_id="E2" events="92" subjects_affected="75" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Insulin-requiring type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Iron deficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ketoacidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lactic acidosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metabolic disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metabolic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vitamin B12 deficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acquired claw toe</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arthritis reactive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Back disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="4668"/>
                <counts group_id="E2" events="21" subjects_affected="20" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Compartment syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diastasis recti abdominis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dupuytren's contracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Fracture nonunion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intervertebral disc displacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="4668"/>
                <counts group_id="E2" events="27" subjects_affected="23" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Meniscal degeneration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mobility decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Muscle haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neuropathic arthropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Osteitis deformans</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="80" subjects_affected="75" subjects_at_risk="4668"/>
                <counts group_id="E2" events="69" subjects_affected="64" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Osteolysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sacroiliitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Spinal instability</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Synovitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Trigger finger</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ulnocarpal abutment syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vertebral foraminal stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of the cervix</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Adrenal adenoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Adrenal neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Anal squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Angiomyolipoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>B-cell unclassifiable lymphoma low grade</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="17" subjects_affected="14" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Basosquamous carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Benign anorectal neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Benign breast neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of prostate</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of thyroid gland</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Benign ovarian tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Benign soft tissue neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Biliary adenoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder cancer stage 0, with cancer in situ</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder cancer stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder squamous cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blepharal papilloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bone neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bowen's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Breast cancer female</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Breast cancer in situ</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour of the small bowel</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour pulmonary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Central nervous system lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebellar tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebral haemangioma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholesteatoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholesterol granuloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chondrosarcoma metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chondrosarcoma recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia stage 1</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic myeloid leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic myelomonocytic leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Clear cell renal cell carcinoma</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="4668"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colon cancer stage 0</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colorectal adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diffuse large B-cell lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Endometrial adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Extranodal marginal zone B-cell lymphoma (MALT type)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Follicle centre lymphoma, follicular grade I, II, III stage I</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Follicle centre lymphoma, follicular grade I, II, III stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gallbladder adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastric cancer stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stromal tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastrointestinal tract adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Giant cell tumour of tendon sheath</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Glioblastoma multiforme</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Glomus tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemangioma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemangioma of bone</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemangioma of spleen</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hairy cell leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatic cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatocellular carcinoma</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypopharyngeal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intraductal papillary mucinous neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intraductal proliferative breast lesion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Invasive breast carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Invasive lobular breast carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Keratoacanthoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Large cell lung cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Large granular lymphocytosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Large intestine benign neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer stage I</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Laryngeal squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lip squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Liposarcoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Liposarcoma metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage IV</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage III</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Malignant glioma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Malignant melanoma in situ</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of pleura</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Medullary thyroid cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Melanocytic naevus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Meningioma benign</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mesothelioma malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastases to peritoneum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastases to spine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastatic bronchial carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastatic malignant melanoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastatic renal cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metastatic squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mucinous breast carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Myxofibrosarcoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neoplasm of appendix</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neoplasm skin</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma of the skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage I</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oesophageal cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oesophageal squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oesophageal squamous cell carcinoma stage IV</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Oropharyngeal cancer stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ovarian adenoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ovarian cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ovarian epithelial cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ovarian epithelial cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pancreatic neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Papillary cystadenoma lymphomatosum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Papillary serous endometrial carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Parathyroid tumour benign</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pelvic neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Phyllodes tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Plasma cell myeloma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Plasmacytoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pleural mesothelioma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="4668"/>
                <counts group_id="E2" events="39" subjects_affected="39" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Prostate cancer recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Prostate cancer stage II</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rectal adenocarcinoma</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rectal adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rectal cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rectal cancer stage II</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal cancer recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma stage II</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Salivary gland neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Seborrhoeic keratosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the cervix</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the oral cavity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the tongue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the vulva</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thyroid adenoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tonsil cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urinary tract neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Uterine leiomyosarcoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vocal cord neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vulval neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Autonomic nervous system imbalance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Basal ganglia haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Basal ganglia stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Brain stem infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carotid arteriosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carotid artery aneurysm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="30" subjects_affected="28" subjects_at_risk="4668"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cauda equina syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebellar haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebellar ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebral haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebral hypoperfusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="4668"/>
                <counts group_id="E2" events="21" subjects_affected="20" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebral small vessel ischaemic disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="56" subjects_affected="52" subjects_at_risk="4668"/>
                <counts group_id="E2" events="68" subjects_affected="65" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebrovascular insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cervical myelopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cervical radiculopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic inflammatory demyelinating polyradiculoneuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dementia with Lewy bodies</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic mononeuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="12" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dyskinesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Embolic cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Generalised tonic-clonic seizure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Guillain-Barre syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemorrhagic cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hemiplegia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypertensive encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic coma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic seizure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic unconsciousness</sub_title>
                <counts group_id="E1" events="24" subjects_affected="21" subjects_at_risk="4668"/>
                <counts group_id="E2" events="28" subjects_affected="28" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischaemic encephalopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>IIIrd nerve disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intercostal neuralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Internal carotid artery kinking</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="54" subjects_affected="50" subjects_at_risk="4668"/>
                <counts group_id="E2" events="59" subjects_affected="54" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mononeuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Multiple system atrophy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Myasthenia gravis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nervous system disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neuritis cranial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Normal pressure hydrocephalus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Orthostatic intolerance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Paraplegia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Parkinsonism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral nerve lesion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peroneal nerve palsy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Petit mal epilepsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post herpetic neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Post-traumatic headache</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Restless legs syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Reversible ischaemic neurological deficit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Seizure like phenomena</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Serotonin syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Spinal claudication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Status epilepticus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="43" subjects_affected="39" subjects_at_risk="4668"/>
                <counts group_id="E2" events="27" subjects_affected="26" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thalamic infarction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thrombotic cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thrombotic stroke</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Toxic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="57" subjects_affected="52" subjects_at_risk="4668"/>
                <counts group_id="E2" events="73" subjects_affected="68" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Unresponsive to stimuli</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Uraemic encephalopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>VIIth nerve paralysis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vascular dementia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vertebral artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vocal cord paralysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="11" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mania</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Personality disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Somatisation disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="124" subjects_affected="108" subjects_at_risk="4668"/>
                <counts group_id="E2" events="105" subjects_affected="94" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder diverticulum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder dysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder hypertrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder neck obstruction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder outlet obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder prolapse</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bladder stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" events="60" subjects_affected="52" subjects_at_risk="4668"/>
                <counts group_id="E2" events="55" subjects_affected="52" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Fibrillary glomerulonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Focal segmental glomerulosclerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis membranous</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Glomerulosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemorrhage urinary tract</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mesangioproliferative glomerulonephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Microalbuminuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="27" subjects_affected="26" subjects_at_risk="4668"/>
                <counts group_id="E2" events="22" subjects_affected="21" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="15" subjects_affected="13" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nephropathy toxic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nocturia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Obstructive uropathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pelvi-ureteric obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal artery arteriosclerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="21" subjects_affected="20" subjects_at_risk="4668"/>
                <counts group_id="E2" events="33" subjects_affected="31" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal infarct</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal tubular necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Single functional kidney</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Tubulointerstitial nephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ureteral necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ureteral polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ureteric obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ureteric stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urinary bladder polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urinary tract obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Acquired phimosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="4668"/>
                <counts group_id="E2" events="23" subjects_affected="23" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Breast mass</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cervical dysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cervical polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Genital prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haematospermia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peyronie's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Prostatic dysplasia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Testicular cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Testicular mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Testicular necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Uterine polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vaginal fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vaginal prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute interstitial pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" events="15" subjects_affected="13" subjects_at_risk="4668"/>
                <counts group_id="E2" events="13" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="23" subjects_affected="22" subjects_at_risk="4668"/>
                <counts group_id="E2" events="21" subjects_affected="18" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Asphyxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="14" subjects_affected="12" subjects_at_risk="4668"/>
                <counts group_id="E2" events="23" subjects_affected="14" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Asthmatic crisis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bronchial hyperreactivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bronchopneumopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="6" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="68" subjects_affected="50" subjects_at_risk="4668"/>
                <counts group_id="E2" events="82" subjects_affected="59" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic respiratory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dependence on respirator</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="21" subjects_affected="20" subjects_at_risk="4668"/>
                <counts group_id="E2" events="36" subjects_affected="32" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hepatopulmonary syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypercapnia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Idiopathic pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Laryngeal dysplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Laryngeal oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Laryngeal stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nasal septum deviation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nasopharyngeal polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Non-cardiogenic pulmonary oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Obstructive airways disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Organising pneumonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Paranasal cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pharyngeal cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pharyngeal inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="18" subjects_affected="15" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pulmonary cavitation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="4668"/>
                <counts group_id="E2" events="26" subjects_affected="24" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="22" subjects_affected="17" subjects_at_risk="4668"/>
                <counts group_id="E2" events="25" subjects_affected="21" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pulmonary sarcoidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="20" subjects_affected="18" subjects_at_risk="4668"/>
                <counts group_id="E2" events="21" subjects_affected="19" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Restrictive pulmonary disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rhinitis hypertrophic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sinus polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Status asthmaticus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Upper airway obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vocal cord polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Actinic elastosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Actinic keratosis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Alopecia areata</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic pigmented purpura</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Chronic spontaneous urticaria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" events="88" subjects_affected="66" subjects_at_risk="4668"/>
                <counts group_id="E2" events="94" subjects_affected="80" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathic ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic ulcer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemorrhage subcutaneous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Keloid scar</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lichen sclerosus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lividity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Melanocytic hyperplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nail bed inflammation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Necrobiosis lipoidica diabeticorum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neurodermatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neuropathic ulcer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Parapsoriasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pemphigoid</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Skin necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Stasis dermatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Toxic epidermal necrolysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Urticaria papular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Social stay hospitalisation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Walking disability</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Abdominal panniculectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Abdominoplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Angioplasty</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ankle operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic bypass</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arterial repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arterial stent insertion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arterial therapeutic procedure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Atherectomy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac ablation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker battery replacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker removal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker replacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiac resynchronisation therapy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary bypass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cardiovascular event prophylaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carotid angioplasty</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carotid artery bypass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carotid artery stent insertion</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carotid endarterectomy</sub_title>
                <counts group_id="E1" events="23" subjects_affected="19" subjects_at_risk="4668"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Carotid revascularisation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cataract operation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cerebral revascularisation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Colostomy closure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary angioplasty</sub_title>
                <counts group_id="E1" events="56" subjects_affected="46" subjects_at_risk="4668"/>
                <counts group_id="E2" events="42" subjects_affected="39" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary arterial stent insertion</sub_title>
                <counts group_id="E1" events="117" subjects_affected="110" subjects_at_risk="4668"/>
                <counts group_id="E2" events="136" subjects_affected="112" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary artery bypass</sub_title>
                <counts group_id="E1" events="86" subjects_affected="84" subjects_at_risk="4668"/>
                <counts group_id="E2" events="105" subjects_affected="102" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Coronary revascularisation</sub_title>
                <counts group_id="E1" events="144" subjects_affected="120" subjects_at_risk="4668"/>
                <counts group_id="E2" events="157" subjects_affected="132" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Deep brain stimulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Endarterectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastric banding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastric bypass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Gastroplasty</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hospitalisation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator insertion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator replacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Inguinal hernia repair</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Ischaemic heart disease prophylaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Joint arthroplasty</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Knee operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lipoma excision</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Medical device battery replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Medical device change</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Mitral valve replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Obesity surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Parathyroidectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Pelvic floor repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Percutaneous coronary intervention</sub_title>
                <counts group_id="E1" events="71" subjects_affected="59" subjects_at_risk="4668"/>
                <counts group_id="E2" events="66" subjects_affected="57" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral artery angioplasty</sub_title>
                <counts group_id="E1" events="25" subjects_affected="20" subjects_at_risk="4668"/>
                <counts group_id="E2" events="29" subjects_affected="27" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral artery bypass</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="19" subjects_affected="14" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral artery stent insertion</sub_title>
                <counts group_id="E1" events="10" subjects_affected="7" subjects_at_risk="4668"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral endarterectomy</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral revascularisation</sub_title>
                <counts group_id="E1" events="33" subjects_affected="29" subjects_at_risk="4668"/>
                <counts group_id="E2" events="47" subjects_affected="36" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Prophylaxis against dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Rehabilitation therapy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal artery stent placement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Renal revascularisation surgery</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Skin graft</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Spinal decompression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Stent placement</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thrombectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vascular graft</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vascular operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vascular stent insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Wrist surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Air embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic arteriosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="4668"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood pressure fluctuation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Blood pressure inadequately controlled</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="23" subjects_affected="20" subjects_at_risk="4668"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Diabetic vascular disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Dry gangrene</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Granulomatosis with polyangiitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="36" subjects_affected="32" subjects_at_risk="4668"/>
                <counts group_id="E2" events="27" subjects_affected="25" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="18" subjects_affected="14" subjects_at_risk="4668"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="4668"/>
                <counts group_id="E2" events="17" subjects_affected="16" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Iliac artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Internal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Labile hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Leriche syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lymphocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Malignant hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Microangiopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Necrosis ischaemic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Neurogenic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Penetrating atherosclerotic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="27" subjects_affected="24" subjects_at_risk="4668"/>
                <counts group_id="E2" events="38" subjects_affected="34" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="4668"/>
                <counts group_id="E2" events="19" subjects_affected="12" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral artery thrombosis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="4668"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral circulatory failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="4668"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="4668"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Peripheral venous disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Phlebosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Steal syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Subclavian artery stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Subgaleal haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thromboangiitis obliterans</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis superficial</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4668"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Vasculitis necrotising</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4668"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="684" subjects_at_risk="4668"/>
                <counts group_id="E2" subjects_affected="210" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="355" subjects_affected="266" subjects_at_risk="4668"/>
                <counts group_id="E2" events="124" subjects_affected="102" subjects_at_risk="4672"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="655" subjects_affected="517" subjects_at_risk="4668"/>
                <counts group_id="E2" events="149" subjects_affected="129" subjects_at_risk="4672"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Global Clinical Registry (GCR, 1452)</name_or_title>
      <organization>Novo Nordisk A/S</organization>
      <email>clinicaltrials@novonordisk.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

